Clinical Trial Update: Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating telbivudine in treatment-naïve patients with HBeAg-positive chronic hepatitis B has been terminated, with results posted in 2011, rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis | Conditions: Hepatitis B | Phase 3 | Status: TERMINATED | Results posted: 2011-07-13